Showing 1 - 20 results of 46 for search '"Breast cancer', query time: 0.13s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Cost-effectiveness of trastuzumab deruxtecan for previously treated HER2-low advanced breast cancer by Demin Shi, Xueyan Liang, Yan Li, Lingyuan Chen

    Published 2023-01-01
    “…<h4>Objective</h4> The clinical efficacy and safety profile of trastuzumab deruxtecan (T-DXd) have been demonstrated in previously treated patients with human epidermal growth factor receptor 2 (HER2)-low advanced breast cancer (BC). It is, however, necessary to evaluate the value of T-DXd considering both its clinical efficacy and its cost, given that it is high. …”
    Get full text
    Article
  12. 12
  13. 13

    Cost-effectiveness of trastuzumab deruxtecan for previously treated HER2-low advanced breast cancer. by Demin Shi, Xueyan Liang, Yan Li, Lingyuan Chen

    Published 2023-01-01
    “…<h4>Objective</h4>The clinical efficacy and safety profile of trastuzumab deruxtecan (T-DXd) have been demonstrated in previously treated patients with human epidermal growth factor receptor 2 (HER2)-low advanced breast cancer (BC). It is, however, necessary to evaluate the value of T-DXd considering both its clinical efficacy and its cost, given that it is high. …”
    Get full text
    Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Non-alcoholic fatty liver disease promotes breast cancer progression through upregulated hepatic fibroblast growth factor 21 by Yue Sui, Qingqing Liu, Cong Xu, Kumar Ganesan, Zhen Ye, Yan Li, Jianmin Wu, Bing Du, Fei Gao, Cailu Song, Jianping Chen

    Published 2024-01-01
    “…Abstract Non-alcoholic fatty liver disease (NAFLD) has been shown to influence breast cancer progression, but the underlying mechanisms remain unclear. …”
    Get full text
    Article
  19. 19

    Case report: Urothelial injury in a female with breast cancer: a rare adverse event after the combination of paclitaxel and trastuzumab by Tinghua Cao, Zhipei Duan, Jing Zhu, Jing Wu, Jun Chen, Mingjun Jiang, Xialiang Lu, Yan Li

    Published 2024-01-01
    “…Several breast cancer (BC) patients showed urinary tract infection after adjuvant trastuzumab plus paclitaxel, but no case of urothelial injury has been reported. …”
    Get full text
    Article
  20. 20